OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS
Quick
Links
Past Charts
Chart of the Week
Chart of the Week
The Viridian Capital Chart of the Week highlights key investment, valuation and M&A trends taken from that week’s Deal Tracker that we believe are impactful for investors, companies and acquirers.
Week ended 05/10/2024
Viridian Capital Chart of the Week: Analysts React Meekly to Strong Q1’24 Earnings
- In our January 2024 outlook, we asserted that cannabis equity analysts, having been burned by the need for continual downward revisions in 2023, were undershooting in their 2024 & 2025 estimates. First quarter results are now in for ten major MSOs, and the results lend credence to our claims.
- The chart depicts the percentage beat (miss) for revenues and EBITDA for Q1’24 and the subsequent percentage revision to consensus 2024 EBITDA estimates. The chart is organized in order of increasing percentage Q1 EBITDA beats.
- The blue line on the chart shows the percentage revenue beat (miss). Four of the companies missed their estimates by amounts that ranged from -.09% for Curaleaf to -3.24% for Cannabist. The group, in the aggregate, beat estimates by about 1.4%.
- EBITDA beats, shown by the orange line, were more significant. Three companies missed estimates, with the biggest miss from MariMed (off by 10%). The beats were generally more substantial, with TerrAscend, Ascend, and Green Thumb turning in results that were over 5% better than estimates. Jushi, Goodness Growth, and Trulieve all beat EBITDA estimates by more than 25%. The group, in the aggregate, beat EBITDA estimates by $37M (9.47%).
- The most significant driver of increased EBITDA was higher margins. Eight of the ten companies beat EBITDA margin estimates.
- Although the group EBITDA beat estimates by $37M, full-year EBITDA estimates have only been increased by $14M. Consensus 2024 estimates have actually been cut for six of the ten companies over the last month! Furthermore, full-year margins for the group are now projected to be 25.96%, lower than the 26.65% actual for the first quarter. The first quarter is seasonally the weakest quarter and first quarter margins have been lower that full-year margins for the last two years.
- Analysts are again playing catch up, but thankfully, this time in the upward direction.
